Published on Web 06/03/2005
Efficient Preparation of Organic Substrate-RNA Conjugates
via in Vitro Transcription
Roberto Fiammengo, Kamil Mus´ılek, and Andres Ja¨schke*
Contribution from the Institute of Pharmacy and Molecular Biotechnology, UniVersity of
Heidelberg, Im Neuenheimer Feld 364, 69120 Heidelberg, Germany
Received February 24, 2005; E-mail: jaeschke@uni-hd.de
Abstract: A concise synthetic way has been developed for the preparation of guanosine monophosphate
derivatives carrying a decaethylene glycol spacer at their 5′-oxygen to which are attached a range of organic
substrates. The four different compounds, prepared via a convergent synthetic strategy, carry a tethered
benzylallyl ether residue (1a), an anthracene (1b), a benzyl carbamate residue (1c), or a primary amino
group (1d), respectively. All four compounds have been successfully incorporated at the 5′-end of a 25-
mer long RNA transcript via T7 RNA polymerase, and no inhibition of chain elongation could be observed.
Under proper conditions, 1a and 1b can be incorporated up to 90-95% and 1c up to 68%. The amino-
terminated initiator 1d is incorporated less efficiently although still up to 49%. These results show that the
more hydrophobic the guanosine monophosphate derivative is, the higher is its enzymatic incorporation.
Introduction
during in vitro selection, as they are either incompatible with
the enzymatic steps or not selective or reliable enough for
In vitro selection and in vitro evolution techniques1,2 have
been used to isolate a large number of RNA catalysts3-5 and
RNA aptamers from combinatorial libraries (pools).6-8 If new
RNA catalysts are to be discovered via in vitro selection, a
substrate must be covalently attached to every sequence of the
RNA pool. This is especially true when attempting the direct
selection of ribozymes that catalyze a reaction between small
organic substrates.9,10 In these cases, the biopolymeric part is
catalyzing the reaction between a covalently linked reactant and
a free reactant without being itself modified. The occurrence
of the desired reaction should nevertheless bring about a change
which allows preparative isolation of the active RNA sequences,
i.e. those that catalyze the reaction. For instance, the reaction
of the RNA-attached substrate with a second substrate could
allow tagging of the active sequences with biotin.10-12 The
biotinylated sequences can then be isolated from the rest of the
pool, enzymatically copied and amplified, and used as input
for the next round of the iterative in vitro selection process.
While chemical methods are known for the covalent attachment
of small organic moieties to RNA, most of them cannot be used
derivatizing complex mixtures such as combinatorial pools of
nucleic acids.
In vitro transcription from DNA templates by DNA-dependent
T7 RNA polymerase, on the other hand, is a simple and reliable
enzymatic method allowing the synthesis of virtually any RNA
sequence.13,14 Using this method guanosine monophosphate
derivatives can be incorporated selectively at the 5′-end of a
transcribed oligoribonucleotide.15-17 Transcription reactions in
the presence of guanosine derivatives carrying covalently
appended an organic moiety (the reaction substrate during the
selection process) result therefore in the site-specific covalent
attachment of this moiety to the RNA. Most importantly, the
conjugation occurs under very mild conditions, which are in
principle compatible with a wide variety of substrates. Although
very powerful, this method has so far found only limited
application,10,18-20 probably because of the laborious multistep
synthesis required for the preparation of these guanosine
monophosphate derivatives, often named initiator nucleotides.
We report here a more versatile and concise synthetic strategy
for the preparation of initiator nucleotides bearing the potential
substrate attached to the end of a decaethylene glycol spacer
(1a-d). The adopted synthetic scheme is highly convergent and
(1) Bittker, J. A.; Phillips, K. J.; Liu, D. R. Curr. Opin. Chem. Biol. 2002, 6,
367-374.
(2) Breaker, R. R. Chem. ReV. 1997, 97, 371-390.
(3) Wilson, D. S.; Szostak, J. W. Annu. ReV. Biochem. 1999, 68, 611-647.
(4) Pan, T. Curr. Opin. Chem. Biol. 1997, 1, 17-25.
(5) Williams, K. P.; Bartel, D. P. In Catalytic RNA; Eckstein, F., Lilley, D.
M. J., Eds.; Springer: Berlin, 1996; Vol. 10, pp 367-381.
(6) Murphy, M. B.; Fuller, S. T.; Richardson, P. M.; Doyle, S. A. Nucleic
Acids Res. 2003, 31, e110.
(13) Milligan, J. F.; Groebe, D. R.; Witherell, G. W.; Uhlenbeck, O. C. Nucleic
Acids Res. 1987, 15, 8783-8798.
(14) Milligan, J. F.; Uhlenbeck, O. C. Methods Enzymol. 1989, 180, 51-62.
(15) Martin, C. T.; Muller, D. K.; Coleman, J. E. Biochemistry 1988, 27, 3966-
3974.
(7) Famulok, M.; Mayer, G.; Blind, M. Acc. Chem. Res. 2000, 33, 591-599.
(8) Famulok, M. Curr. Opin. Struct. Biol. 1999, 9, 324-329.
(9) Keiper, S.; Bebenroth, D.; Seelig, B.; Westhof, E.; Ja¨schke, A. Chem. Biol.
2004, 11, 1217-1227.
(16) Contreras, R.; Cheroutre, H.; Degrave, W.; Fiers, W. Nucleic Acids Res.
1982, 10, 6353-6362.
(17) Konarska, M. M.; Padgett, R. A.; Sharp, P. A. Cell 1984, 38, 731-736.
(18) Eisenfuhr, A.; Arora, P. S.; Sengle, G.; Takaoka, L. R.; Nowick, J. S.;
Famulok, M. Bioorg. Med. Chem. 2003, 11, 235-249.
(19) Zhang, L.; Sun, L.; Cui, Z.; Gottlieb, R. L.; Zhang, B. Bioconjugate Chem.
2001, 12, 939-948.
(10) Sengle, G.; Eisenfuhr, A.; Arora, P. S.; Nowick, J. S.; Famulok, M. Chem.
Biol. 2001, 8, 459-473.
(11) Jadhav, V. R.; Yarus, M. Biochemistry 2002, 41, 723-729.
(12) Seelig, B.; Ja¨schke, A. Chem. Biol. 1999, 6, 167-176.
(20) Seelig, B.; Ja¨schke, A. Bioconjugate Chem. 1999, 10, 371-378.
9
10.1021/ja051179m CCC: $30.25 © 2005 American Chemical Society
J. AM. CHEM. SOC. 2005, 127, 9271-9276
9271